Gianfranco Nazzi is EVP, International Markets of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 0 shares of TEVA, which is worth approximately $0. The most recent transaction as insider was on Mar 04, 2021, when has been sold 12,935 shares (Ordinary Shares) at a price of $10.58 per share, resulting in proceeds of $136,852. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Gianfranco Nazzi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2021
SELL
Open market or private sale
$136,852 $10.58 p/Share
12,935 Reduced 100.0%
0 Ordinary Shares
Mar 04 2021
BUY
Grant, award, or other acquisition
-
12,935 Added 50.0%
12,935 Ordinary Shares
Mar 03 2021
SELL
Open market or private sale
$15,232 $10.88 p/Share
1,400 Reduced 100.0%
0 Ordinary Shares
Mar 03 2021
BUY
Exercise of conversion of derivative security
-
1,400 Added 50.0%
1,400 Ordinary Shares
Mar 01 2021
SELL
Open market or private sale
$821,631 $10.87 p/Share
75,587 Reduced 100.0%
0 Ordinary Shares
Feb 28 2021
BUY
Exercise of conversion of derivative security
-
15,177 Added 16.72%
75,587 Ordinary Shares
Feb 09 2021
SELL
Open market or private sale
$275,197 $12.72 p/Share
21,635 Reduced 26.37%
60,410 Ordinary Shares
Feb 09 2021
BUY
Grant, award, or other acquisition
-
50,260 Added 37.99%
82,045 Ordinary Shares
Feb 09 2021
BUY
Exercise of conversion of derivative security
-
11,941 Added 27.31%
31,785 Ordinary Shares
GN

Gianfranco Nazzi

EVP, International Markets
Petach Tikva, L3

Track Institutional and Insider Activities on TEVA

Follow TEVA PHARMACEUTICAL INDUSTRIES LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if
Any

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Track Activities on TEVA